Probiotics-supplemented feeding in extremely low-birth-weight infants

Journal of Perinatology

Volumn 32, Issue 4, 2012, Pages 253-259

  Al Hosni, M ^a   Duenas, M ^b   Hawk, M ^c   Stewart, L A ^b   Borghese, R A ^d   Cahoon, M ^e   Atwood, L ^e   Howard, D ^f   Ferrelli, K ^g   Soll, R ^e,f  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

^c SSM Cardinal Glennon Children's Medical Center   (United States)

^d University of California at Davis School of Medicine   (United States)

^e FLETCHER ALLEN HEALTH CARE   (United States)

^f UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^g VERMONT OXFORD NETWORK   (United States)

Author keywords

extremely low birth weight; necrotizing enterocolitis; post menstrual age; probiotics supplementation; very low birth weight

Indexed keywords

ANTIINFECTIVE AGENT; PROBIOTIC AGENT;

ARTICLE; BIFIDOBACTERIACEAE; CHILD GROWTH; CLINICAL EVALUATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; EXTREMELY LOW BIRTH WEIGHT; FEMALE; GROWTH RATE; HUMAN; INFANT; INFANT FEEDING; INFANT MORTALITY; LACTOBACILLACEAE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEWBORN ASSESSMENT; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ACADEMIC MEDICAL CENTERS; BIFIDOBACTERIUM; BIRTH WEIGHT; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; MALE; PILOT PROJECTS; PROBIOTICS; PROSPECTIVE STUDIES; STREPTOCOCCACEAE; WEIGHT GAIN;

EID: 84859434031     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2011.51     Document Type: Article

References (40)

1. Horbar JD, Badger GJ, Carpenter JH, Fanaroff AA, Kilpatrick S, LaCorte M et al. Trends in mortality and morbidity for very low birth weight infants 1991-1999. Pediatrics 2002; 110: 143-151. (Pubitemid 34742654)
2. Morley R, Lucas A. Influence of early diet on outcome in preterm infants. Acta Paediatr Suppl 1994; 405: 123-126.
3. Franz AR, Pohlandt F, Bode H, Mihatsch WA. Intrauterine, earlynonatal, and postdischarge growth neurodevelopmental outcome at 5.4 years in extremely preterm infants after intenstive neonatal nutritional support. Pediatrics 2009; 123: e101-e109.
4. Millar M, Wilks M, Costeloe K. Probiotics for preterm infants. Arch Dis Child Fetal Neonatal Ed 2003; 88: F354-F358.
5. Martin CR, Walker WA. Probiotics: role in pathophysiology and prevention in necrotizing enterocolitis. Semin Perinatol 2008; 32: 127-137. (Pubitemid 351381168)
6. Caplan M, Tamas J. Neonatal Necrotizing Enterocolitis: Possible role of probiotic supplementation. J pediatr Gastroenterol Nutr 2000; 30(2): S18-S22. (Pubitemid 30341459)
7. Mack DR, Michail S, Wei S. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol 1999; 276: G950.
8. Mohan R, Koebnick C, Schildt J. Effect of Bifidobacterium lactis Bb12 supplementation on intestinal microbiota of preterm neonates: a double placebo controlled, randomized study. J Clin Microbiol 2006; 44: 4025-4031. (Pubitemid 44737246)
9. Deplancke B, Gaskins HR. Microbial modulation of innate defense: goblet cells and the intestinal mucus layer. Am J Clin Nutr 2001; 73: 1131S-1141S. (Pubitemid 32496957)
10. Madsen K, Cornish A, Soper P. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 2001; 121: 580-591. (Pubitemid 32822573)
11. Kennedy RJ, Kirk SJ, Gardiner KR. Mucosal barrier function and the commensal flora. Gut 2002; 50: 441-442. (Pubitemid 34161068)
12. Orrhage K, Nord CE. Factors controlling the bacterial colonization of the intestine in breastfed infants. Acta Paediatr 1999; (Suppl 88): 47-57. (Pubitemid 29489143)
13. Panigrahi P, Gupta S, Gewolb IH. Occurrence of necrotizing enterocolitis may be dependent on patterns of bacterial adherence and intestinal colonization: studies in Caco-2 tissue culture and weanling rabbit models. Pediatr Res 1994; 36: 115-121.
14. Sudo N, Sawamura S, Tanaka K. The requirement of intestinal bacterial flora for the development of IgE production system fully susceptible to oral tolerance induction. J Immunol 1997; 159: 1739-1745. (Pubitemid 127484159)
15. Fukushima Y, Kawata Y, Hara H. Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. Int J Food Microbiol 1998; 42: 39-44. (Pubitemid 28370327)
16. Schiffrin EJ, Rochat F, Link-Amster H. Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. J Dairy Sci 1995; 78: 491-497.
17. Weng M, Walker WA, Sanderson IR. Butyrate regulates the expression of pathogen-triggered IL-8 in intestinal epithelia. Pediatr Res 2007; 62: 542-546. (Pubitemid 351338987)
18. Viljanen M, Kuitunen M, Haahtela T. Probiotic effects on faecal inflammatory markers and on faecal IgA in food allergic atopic eczema/dermatitis syndrome infants. Pediatr Allergy Immunol 2005; 16: 65-71. (Pubitemid 40313966)
19. Marin ML, Tejada-Simon MV, Lee JH. Stimulation of cytokine production in clonal macrophages and T-cell models by Streptococcus thermophilus: comparison with Bifidobacterium sp. and Lactobaillus bulgarius. J Food Prot 1998; 61: 859-864. (Pubitemid 28348609)
20. Murch SH. Toll of allergy reduced by probiotics. Lancet 2001; 357: 1057-1059. (Pubitemid 32322532)
21. Klinman DM, Yi AK, Beaucage SL. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete IL-6, IL-12 and interferon gamma. Proc Natl Acad Sci USA 1996; 93: 2879-2883. (Pubitemid 26116242)
22. Fujii T, Ohtsuka Y, Lee T. Bifidobacterium breve enhances transforming growth factor betal signaling by regulating Smad7 expression in preterm infants. J Pediatr gastroenterol Nutr 2006; 43: 83-88. (Pubitemid 44022391)
23. Takeda K, Suzuki T, Shimada SI. Interleukin-12 involved in the enhancement of human natural killer cell activity by Lactobacillus casei Shirota. Clin Exp Immunol 2006; 146: 109-115. (Pubitemid 44393845)
24. Kitajima H, Sumida Y, Tanaka R, Yuki N, Takayama H, Fujimura M. Early administration of Bifidobacterium breve to preterm infants: randomized controlled trial. Arch Dis Child Fetal Neonatal Ed 1997; 76: f101-f107. (Pubitemid 28201543)
25. Rouge C, Piloquet H, Butel M, Rochat F, Ferraris L. Oral supplementation with probiotics in very low birth weight preterm infants: a randomized, double-blind, placebo-controlled trial. Am J clin Nutr 2009; 89: 1828-1835.
26. Dani C, Biadaioli R, Bertini G, Martelli E, Rubaltelli F. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. Biol Neonate 2002; 82: 103-108.
27. Costalos C, Skouteri V, Gounaris A. Enteral feeding of premature neonates with Saccharomyces boulardii. Early Hum Dev 2003; 74: 89-96. (Pubitemid 37315841)
28. Bin-Nun A, Bromiker R, Wilschanski M, Kaplan M, Rudensky B, Caplan M et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr 2005; 147: 192-196. (Pubitemid 41207832)
29. Lin HC, Su BH, Chen AC. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2005; 115: 1-4.
30. Manzoni P, Mostert M, Leonessa ML. Oral supplementation with Lactobacillus casei subspecies in preterm neonates: a randomized study. Clin Infect Dis 2006; 42: 1735-1742.
31. Startiki Z, Costalos C, Sevastiadou S. The effect of bifidobacter supplemented bovine milk on intestinal permeability of preterm infants. Early Hum Dev 2007; 83: 575-579. (Pubitemid 47380129)
32. Lin HC, Hsu CH, Chen HL, Chung MY, Hsu JF, Lien RI et al. Oral robiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: A multicenter randomized controlled trial. Pediatrics 2008; 122: 693-700.
33. Samanta M, Sarkar M, Ghosh P. Prophylactic probiotics for prevention of necrotizing enterocolitis in very low birth weight newborns. J Trop Pediatr 2009; 55(2): 128-131.
34. Deshpande G, Rao S, Patole S, Bulsara M. Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics 2010; 125(5): 921-930.
35. Soll R. Probiotic: are we ready for routine use? Pediatrics 2010; 125(5): 1071-1072.
36. Patel A, Engstrom J, Meier P, Kimura R. Accuracy of methods for calculating postnatal growth velocity for extremely low birth weight infants. Pediatrics 2005; 116(6): 1466-1473. (Pubitemid 46056496)
37. Kunz AN, Fairchik MP, Noel JM. Lactobacillus sepsis associated with probiotic therapy. Pediatrics 2005; 115(1): 178-181.
38. Sullivan A, Nord CE. Probiotic lactobacilli and bacteraemia in Stockholm. Scand J Infect Dis 2006; 38(5): 327-331. (Pubitemid 43832396)
39. Presterl E, Kneifel W, Mayer HK, Zehetgruber M, makristathis A, Graninger W. Endocarditis by Lactobacillus rhamnosus due to yogurt ingestion? Scand J Infect Dis 2001; 33(9): 710-714. (Pubitemid 32962866)
40. Ohishi A, Takahashi S, Ito Y, Ohishi Y, Tsukamoto K, Nanba Y et al. Bifidobacterium septicemia associated with postoperative probiotic therapy in a neonate with omphalocele. J Peds 2010; 156(4): 679-681.